Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell Transplantation

Documenti analoghi

• Low Dose of IL‐2 Application for Graft‐Versus‐Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation
  di: Zheng‐Li Xu, et al.
  Pubblicazione: (2026)
• Gut Microbiome and Metabolome Dynamics as Predictors of Clinical Outcomes in Hematopoietic Stem Cell Transplantation
  di: Juewon Kim, et al.
  Pubblicazione: (2025)
• The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer
  di: Jie Dou, et al.
  Pubblicazione: (2025)
• PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop
  di: Fan Yang, et al.
  Pubblicazione: (2025)
• Stable Expressed DNMT3A Mutants Predict a Poor Prognosis in Acute Myeloid Leukemia Patients Without Receiving Hematopoietic Stem Cell Transplantation
  di: Xiang Zhang, et al.
  Pubblicazione: (2025)